1. Home
  2. NTRA vs SHG Comparison

NTRA vs SHG Comparison

Compare NTRA & SHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • SHG
  • Stock Information
  • Founded
  • NTRA 2003
  • SHG 1982
  • Country
  • NTRA United States
  • SHG South Korea
  • Employees
  • NTRA N/A
  • SHG N/A
  • Industry
  • NTRA Medical Specialities
  • SHG Major Banks
  • Sector
  • NTRA Health Care
  • SHG Finance
  • Exchange
  • NTRA Nasdaq
  • SHG Nasdaq
  • Market Cap
  • NTRA 21.5B
  • SHG 21.1B
  • IPO Year
  • NTRA 2015
  • SHG N/A
  • Fundamental
  • Price
  • NTRA $160.29
  • SHG $45.17
  • Analyst Decision
  • NTRA Strong Buy
  • SHG
  • Analyst Count
  • NTRA 16
  • SHG 0
  • Target Price
  • NTRA $185.56
  • SHG N/A
  • AVG Volume (30 Days)
  • NTRA 1.3M
  • SHG 174.2K
  • Earning Date
  • NTRA 08-07-2025
  • SHG 07-25-2025
  • Dividend Yield
  • NTRA N/A
  • SHG 2.67%
  • EPS Growth
  • NTRA N/A
  • SHG 10.40
  • EPS
  • NTRA N/A
  • SHG 5.99
  • Revenue
  • NTRA $1,831,000,000.00
  • SHG $9,943,536,795.00
  • Revenue This Year
  • NTRA $19.92
  • SHG $4.00
  • Revenue Next Year
  • NTRA $16.02
  • SHG $2.67
  • P/E Ratio
  • NTRA N/A
  • SHG $7.38
  • Revenue Growth
  • NTRA 51.50
  • SHG 0.69
  • 52 Week Low
  • NTRA $92.14
  • SHG $28.76
  • 52 Week High
  • NTRA $183.00
  • SHG $46.05
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 44.76
  • SHG 73.51
  • Support Level
  • NTRA $159.50
  • SHG $43.83
  • Resistance Level
  • NTRA $170.48
  • SHG $44.54
  • Average True Range (ATR)
  • NTRA 5.31
  • SHG 0.57
  • MACD
  • NTRA -1.29
  • SHG -0.06
  • Stochastic Oscillator
  • NTRA 14.77
  • SHG 98.29

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About SHG Shinhan Financial Group Co Ltd

Shinhan Financial Group Co Ltd is a Korean banking group. Along with its subsidiaries the company provides, comprehensive financial services which consist of commercial banking services, credit card services, securities services, insurance, credit services, and asset management services, including securities investment trust management, investment advisory, call transaction, domestic and foreign private equity fund business, and other services. The majority of the revenue is generated from its Banking business which includes retail, corporate, international, and other banking services the company offers.

Share on Social Networks: